1. Hetrick PF, Davidow EB. Initial treatment factors associated with feline urethral obstruction recurrence rate: 192 cases (2004–2010). J Am Vet Med Assoc 2013; 243:512–519.
2. Streater-Knowlen IM, Marks SL, Rishniw M, et al. Urethral pressure response to smooth and skeletal muscle relaxants in anesthetized adult male cats with naturally acquired urethral obstruction. Am J Vet Res 1995; 56:919–923.
3. Wang B, Bhadra N, Grill W. Functional anatomy of the male feline urethra: morphological and physiological correlations. J Urol 1999; 161:654–659.
1. Streater-Knowlen IM, Marks SI, Rinshniw M, et al. Urethral pressure response to smooth and skeletal muscle relaxants in anesthetized adult male cats with naturally acquired urethral obstruction. Am J Vet Res 1995; 56:919–923.
2. Lefevre-Borg F, O'Connor SE, Schoemaker H, et al. Alfuzosin, a selective alpha 1 adrenoceptor antagonist in the lower urinary tract. Br J Pharmacol 1993; 109:1282–1289.
3. Fischer JR, Lane IF, Cribb AE. Urethral pressure profile and hemodynamic effects of phenoxybenzamine and prazosin in nonsedated male Beagle dogs. Can J Vet Res 2003; 67:30–38.
4. Hetrick PF, Davidow EB. Initial treatment factors associated with feline urethral obstruction recurrence rate: 192 cases (2004–2010). J Am Vet Med Assoc 2013; 243:512–519.
1. Strimple EO. Veterinary applicants (lett). J Am Vet Med Assoc 2013; 243:618.
Advertisement
The authors of the article “Initial treatment factors associated with feline urethral obstruction recurrence rate: 192 cases (2004–2010)”
First, to our knowledge, urethral spasms have never been documented in cats. In a study